Raiyyan Tahsan

Raiyyan Tahsan
Hello I'm Raiyyan Tahsan
Brand Model and Executive

TC(931).(20).Sexology Case No 84. Genital Cancers

Genital Cancers — বাংলা একাডেমিক নোট

সতর্কতা: Genital cancer-এর চিকিৎসা stage, histology, fertility desire, renal/hepatic function, ECOG status, mutation profile এবং radiotherapy availability অনুযায়ী নির্ধারিত হয়। নিচের chemotherapy dose গুলো educational protocol dose—oncologist ছাড়া ব্যবহারযোগ্য নয়।

1. Definition / সংজ্ঞা

Genital cancers বলতে নারী ও পুরুষের reproductive/genital organ–এ হওয়া malignant tumour বোঝায়।

Female genital cancers:
Cervical cancer, vulvar cancer, vaginal cancer, endometrial/uterine cancer, ovarian/fallopian tube/primary peritoneal cancer.

Male genital/reproductive cancers:
Penile cancer, testicular cancer, prostate cancer.

Cervical cancer সবচেয়ে HPV-related genital cancer; HPV vaccine cervical, vulvar, vaginal, penile, anal ও oropharyngeal cancer প্রতিরোধে সাহায্য করে।

2. Causes / Etiology & Pathophysiology — কারণগুলো

A. Common causes / risk factors

  1. High-risk HPV infection
    • HPV 16, 18 সবচেয়ে গুরুত্বপূর্ণ।
    • Cervix, vulva, vagina, penis—এসব cancer-এর সাথে strong association।
    • Persistent HPV infection → epithelial dysplasia → carcinoma in situ → invasive cancer.
  2. Early sexual activity / multiple sexual partners
    • HPV exposure বাড়ায়।
  3. Smoking
    • Cervical, vulvar, vaginal ও penile squamous cell carcinoma risk বাড়ায়।
  4. Immunosuppression
    • HIV, transplant drugs, long-term steroid/immunosuppressive therapy → HPV persistence ও cancer risk বাড়ে।
  5. Poor genital hygiene / phimosis
    • Penile cancer risk বাড়ায়।
  6. Chronic inflammation
    • Lichen sclerosus → vulvar SCC risk.
    • Chronic balanitis/phimosis → penile cancer risk.
  7. Hormonal factors
    • Unopposed estrogen, obesity, PCOS, nulliparity → endometrial cancer risk.
  8. Genetic factors
    • BRCA1/BRCA2 mutation → ovarian/fallopian tube cancer risk.
    • Lynch syndrome → endometrial ও ovarian cancer risk.
  9. Cryptorchidism
    • Undescended testis → testicular cancer risk.
  10. Age
  • Cervical cancer middle age; vulvar/endometrial/prostate older age; testicular cancer young adult male.

Genital cancers-এর Cause / Risk factors — বিস্তারিত বাংলা ব্যাখ্যা

Core meaning: Genital cancer সাধারণত একদিনে হয় না। দীর্ঘদিন ধরে DNA damage, persistent infection, hormonal stimulation, chronic inflammation, genetic mutation, এবং immune weakness মিলে normal cell → precancer → cancer cell-এ পরিবর্তিত হয়।

1. HPV infection — সবচেয়ে গুরুত্বপূর্ণ cause

HPV = Human Papillomavirus।
High-risk HPV বিশেষ করে HPV 16, HPV 18 cervical cancer-এর সবচেয়ে বড় কারণ। HPV cervix ছাড়াও vulva, vagina, penis, anus, oropharynx-এর cancer করতে পারে। CDC অনুযায়ী 13টি HPV type cervical cancer cause করতে পারে, এবং HPV cervix, vagina, vulva, penis ও anus cancer-এর সাথে related।

কীভাবে cancer করে?

  • HPV sexual skin-to-skin contact দিয়ে ছড়ায়।
  • বেশিরভাগ HPV infection নিজে নিজে clear হয়ে যায়।
  • কিন্তু persistent high-risk HPV infection থাকলে virus cervix/vulva/vagina/penis-এর epithelial cell-এর DNA control system নষ্ট করে।
  • HPV-এর E6 এবং E7 viral proteins cell-এর tumour suppressor pathway যেমন p53 ও Rb function block করে।
  • ফলে abnormal cell division শুরু হয়।
  • ধীরে ধীরে dysplasia → carcinoma in situ → invasive cancer হতে পারে।

কোন cancer-এ বেশি গুরুত্বপূর্ণ?

  • Cervical cancer — সবচেয়ে strong association
  • Vulvar cancer
  • Vaginal cancer
  • Penile cancer
  • Anal cancer
  • কিছু oropharyngeal cancer

WHO উল্লেখ করেছে যে cervical cancer progression risk বাড়ে HPV type-এর oncogenicity, immune status, other STI, parity, young age at first pregnancy, hormonal contraceptive use ও smoking-এর কারণে।

2. Multiple sexual partners / early sexual exposure

কেন risk বাড়ে?

  • Sexual partner বেশি হলে HPV exposure-এর chance বাড়ে।
  • Early sexual activity-তে cervix-এর transformation zone immature থাকে, তাই HPV infection persistent হওয়ার chance বেশি।
  • Partner-এর previous HPV/STI history থাকলেও risk বাড়ে।

Related cancers

  • Cervical cancer
  • Vaginal cancer
  • Vulvar cancer
  • Penile cancer

এটা direct cancer cause না, কিন্তু HPV acquisition-এর major risk factor।

3. Smoking / tobacco use

Smoking genital cancer-এর important modifiable risk factor।

কীভাবে cancer করে?

  • Tobacco-এর carcinogen genital epithelial tissue ও cervical mucus-এ জমতে পারে।
  • Smoking local immunity কমিয়ে HPV clearance কমায়।
  • HPV থাকলে smoking abnormal cell persistence বাড়ায়।
  • DNA damage, chronic inflammation এবং oxidative stress বাড়ায়।

কোন cancer-এ relevant?

  • Cervical cancer
  • Vulvar cancer
  • Vaginal cancer
  • Penile cancer
  • Prostate cancer-এর ক্ষেত্রে smoking aggressive disease/prognosis খারাপ করতে পারে, যদিও primary cause হিসেবে সবসময় strongest নয়।

CDC বলছে, HPV infection থাকা অবস্থায় smoking করলে body HPV clear করতে কম সক্ষম হতে পারে। Penile cancer-এর ক্ষেত্রে smoking/tobacco, phimosis, HPV, chronic inflammation risk factor হিসেবে উল্লেখ করা হয়েছে।

4. Immunosuppression / immune weakness

Common examples

  • HIV infection
  • Organ transplant-এর পর immunosuppressive drug
  • Long-term steroid
  • Chemotherapy-induced immune suppression
  • Poorly controlled chronic disease

কীভাবে cancer risk বাড়ায়?

  • Immune system সাধারণত HPV-infected abnormal cell ধ্বংস করে।
  • Immunity কমে গেলে HPV persistent হয়।
  • Precancerous lesion regress না করে progress করতে পারে।
  • Viral oncogenesis সহজ হয়।

Related cancers

  • Cervical cancer
  • Vulvar cancer
  • Vaginal cancer
  • Penile cancer
  • Anal cancer

WHO cervical cancer progression-এর risk factor হিসেবে immune status উল্লেখ করেছে।

5. Other sexually transmitted infections

Examples

  • Chlamydia
  • Gonorrhea
  • Herpes simplex virus
  • HIV

কীভাবে risk বাড়ায়?

  • STI genital tract-এ chronic inflammation তৈরি করে।
  • Cervical/vaginal epithelium damaged হয়।
  • HPV infection acquire ও persist করার chance বাড়ে।
  • Repeated inflammation → DNA damage ও abnormal repair process হতে পারে।

WHO cervical cancer progression risk-এর মধ্যে other STI-কে উল্লেখ করেছে।

6. High parity / multiple childbirth

Cervical cancer-এর ক্ষেত্রে গুরুত্বপূর্ণ

কীভাবে risk বাড়ে?

  • বারবার pregnancy ও childbirth cervix-এর transformation zone-এ repeated trauma এবং hormonal change তৈরি করে।
  • HPV-infected cervical epithelial cell-এর persistence ও progression সহজ হতে পারে।
  • Long-term estrogen/progesterone exposure cervical epithelium-এর biological environment পরিবর্তন করে।

WHO cervical cancer progression risk factor হিসেবে number of births উল্লেখ করেছে।

7. Young age at first pregnancy

কীভাবে risk বাড়ে?

  • অল্প বয়সে cervix-এর transformation zone বেশি exposed ও biologically immature থাকে।
  • HPV infection হলে persistent হওয়ার chance তুলনামূলক বেশি।
  • Early pregnancy usually early sexual exposure-এর marker হিসেবেও কাজ করে।

WHO young age at first pregnancy cervical cancer progression risk বাড়াতে পারে বলে উল্লেখ করেছে।

8. Long-term hormonal contraceptive use

Mainly cervical cancer context

কীভাবে risk বাড়তে পারে?

  • Long-term oral contraceptive hormonal environment cervical epithelial response বদলাতে পারে।
  • HPV persistence ও progression-এ hormonal cofactor হিসেবে কাজ করতে পারে।
  • তবে contraceptive-এর benefit ও risk individual basis-এ assess করতে হয়।

WHO cervical cancer progression risk factor-এর মধ্যে hormonal contraceptive use উল্লেখ করেছে।

9. Obesity

Obesity বিশেষ করে endometrial cancer এবং কিছু ovarian cancer risk বাড়ায়।

Endometrial cancer-এ obesity কেন important?

  • Fat tissue androgen থেকে estrogen তৈরি করে।
  • Postmenopausal woman-এর ovary estrogen কম তৈরি করলেও fat tissue estrogen বাড়াতে পারে।
  • Excess estrogen যদি progesterone দ্বারা balanced না হয়, তাহলে endometrium বারবার proliferate করে।
  • দীর্ঘদিন proliferation → endometrial hyperplasia → atypia → endometrial carcinoma হতে পারে।

American Cancer Society অনুযায়ী obesity fat tissue-এর মাধ্যমে estrogen level বাড়িয়ে endometrial cancer risk বাড়ায়।

Ovarian cancer-এ obesity

  • Obesity chronic low-grade inflammation করে।
  • Insulin resistance ও hormonal imbalance তৈরি করে।
  • কিছু ovarian cancer subtype-এর risk বাড়াতে পারে।

NCI/PDQ ovarian cancer risk factors-এর মধ্যে obesity, endometriosis ও postmenopausal hormone therapy উল্লেখ করেছে।

10. Unopposed estrogen exposure

Mainly endometrial cancer

Sources

  • Estrogen-only hormone replacement therapy
  • PCOS
  • Anovulatory cycle
  • Obesity
  • Estrogen-secreting ovarian tumour
  • Early menarche
  • Late menopause
  • Nulliparity

কীভাবে cancer করে?

  • Endometrium estrogen দ্বারা grow করে।
  • Progesterone endometrium-কে secretory phase-এ নিয়ে যায় এবং uncontrolled growth কমায়।
  • Progesterone না থাকলে estrogen continuous stimulation দেয়।
  • Result: endometrial hyperplasia → atypical hyperplasia → carcinoma।

NCI endometrial cancer prevention summary risk factors হিসেবে postmenopausal estrogen use, tamoxifen use ও Lynch syndrome উল্লেখ করেছে।

11. PCOS / chronic anovulation

কীভাবে risk বাড়ে?

  • PCOS-এ অনেক সময় ovulation regular হয় না।
  • Ovulation না হলে progesterone production কম হয়।
  • Estrogen effect unopposed থাকে।
  • Endometrium অতিরিক্ত proliferate করে।
  • Long-term result: endometrial hyperplasia এবং cancer risk।

Related cancer

  • Endometrial cancer

12. Diabetes mellitus / metabolic syndrome

কীভাবে risk বাড়ে?

  • Insulin resistance → hyperinsulinemia।
  • Insulin ও IGF pathway cell proliferation বাড়াতে পারে।
  • Obesity + diabetes + hypertension একসাথে endometrial cancer risk বাড়ায়।
  • Chronic inflammation cancer-promoting environment তৈরি করে।

Related cancers

  • Endometrial cancer
  • কিছু ovarian cancer
  • Prostate cancer prognosis-এর ক্ষেত্রেও metabolic health relevant হতে পারে।

13. Tamoxifen use

Mainly endometrial cancer

Tamoxifen breast cancer-এর treatment/prevention drug, কিন্তু uterus/endometrium-এ partial estrogen agonist effect দিতে পারে।

কীভাবে risk বাড়ায়?

  • Endometrium-এ estrogen-like stimulation করে।
  • Endometrial polyp, hyperplasia এবং cancer risk বাড়াতে পারে।
  • Postmenopausal woman-এ risk বেশি relevant।

NCI endometrial cancer risk factors-এর মধ্যে tamoxifen use উল্লেখ করেছে।

14. Lynch syndrome

কী?

Lynch syndrome হলো inherited DNA mismatch repair gene defect, যেমন MLH1, MSH2, MSH6, PMS2, EPCAM।

কীভাবে cancer করে?

  • DNA replication error repair হয় না।
  • Microsatellite instability হয়।
  • Cell mutation accumulate করে।
  • Endometrial, ovarian, colorectal cancer risk বাড়ে।

NCI অনুযায়ী Lynch syndrome থাকা নারীর lifetime endometrial cancer risk অনেক বেশি হতে পারে।

Related cancers

  • Endometrial cancer
  • Ovarian cancer
  • Colorectal cancer
  • Gastric/urinary tract cancers

15. BRCA1 / BRCA2 mutation

Mainly ovarian/fallopian tube cancer

কীভাবে cancer করে?

  • BRCA genes DNA double-strand break repair করে।
  • BRCA mutation থাকলে DNA repair defective হয়।
  • Fallopian tube fimbria/ovary/peritoneum-এর epithelial cell mutation জমে cancer হতে পারে।

NCI ovarian cancer summary অনুযায়ী প্রায় 20% ovarian cancers familial, এবং এগুলোর অনেকগুলো BRCA1/BRCA2 pathogenic variant-এর সাথে linked।

Related cancers

  • Ovarian cancer
  • Fallopian tube cancer
  • Primary peritoneal cancer
  • Breast cancer
  • কিছু prostate/pancreatic cancer

16. Family history

কেন গুরুত্বপূর্ণ?

Family history থাকলে inherited mutation থাকার chance থাকে।

Examples

  • Mother/sister/daughter ovarian cancer → ovarian cancer risk বাড়ে।
  • Breast + ovarian cancer family history → BRCA suspicion।
  • Colon + endometrial cancer family history → Lynch syndrome suspicion।
  • Father/brother prostate cancer → prostate cancer risk বাড়ে।
  • Brother/father testicular cancer → testicular cancer risk বাড়ে।

NCI prostate cancer risk factors-এর মধ্যে age ও family history উল্লেখ করেছে।

17. Endometriosis

Mainly ovarian cancer

কীভাবে risk বাড়ে?

  • Endometriosis chronic inflammation তৈরি করে।
  • Repeated bleeding ও repair process oxidative stress বাড়ায়।
  • DNA damage হতে পারে।
  • Clear cell ovarian carcinoma এবং endometrioid ovarian carcinoma-এর সাথে association বেশি।

NCI/PDQ ovarian cancer risk factors-এর মধ্যে endometriosis উল্লেখ আছে।

18. Postmenopausal hormone therapy

Mainly endometrial/ovarian cancer

কীভাবে risk বাড়ে?

  • Estrogen-only therapy uterus intact থাকলে endometrial hyperplasia/cancer risk বাড়াতে পারে।
  • Long-term postmenopausal hormone therapy ovarian cancer risk-এর সাথেও associated হতে পারে।

NCI ovarian cancer prevention summary other risk factors হিসেবে postmenopausal hormone therapy উল্লেখ করেছে।

19. Chronic vulvar skin disease — Lichen sclerosus

Mainly vulvar cancer

কীভাবে risk বাড়ে?

  • Lichen sclerosus vulvar skin-এ chronic inflammation, itching, epithelial thinning ও scarring করে।
  • Chronic inflammation ও repeated epithelial repair থেকে squamous cell carcinoma develop হতে পারে।
  • HPV-independent vulvar SCC pathway-তে lichen sclerosus গুরুত্বপূর্ণ।

Cleveland Clinic vulvar cancer risk factor হিসেবে HPV infection ও lichen sclerosus উল্লেখ করেছে।

20. VIN / VAIN / CIN / PeIN — precancerous lesions

Full forms

  • CIN: Cervical intraepithelial neoplasia
  • VIN: Vulvar intraepithelial neoplasia
  • VAIN: Vaginal intraepithelial neoplasia
  • PeIN: Penile intraepithelial neoplasia

কীভাবে cancer করে?

  • এগুলো invasive cancer নয়, কিন্তু abnormal epithelial cell already present থাকে।
  • Untreated high-grade lesion invasive cancer-এ progress করতে পারে।
  • HPV-related বা chronic inflammation-related হতে পারে।

Related cancers

  • Cervical cancer
  • Vulvar cancer
  • Vaginal cancer
  • Penile cancer

21. Poor genital hygiene, phimosis, smegma accumulation

Mainly penile cancer

কীভাবে risk বাড়ে?

  • Phimosis হলে foreskin পিছনে টানা যায় না।
  • Smegma ও chronic irritation জমে থাকে।
  • Chronic balanitis/inflammation হতে পারে।
  • HPV infection persistent হতে পারে।
  • Long-term inflammation squamous cell carcinoma risk বাড়ায়।

American Cancer Society penile cancer risk factors-এর মধ্যে HPV infection, phimosis/chronic inflammation, smoking, older age ও HIV উল্লেখ করেছে।

22. Lack of circumcision — indirect risk factor

কীভাবে?

  • Circumcision না থাকলে phimosis, smegma accumulation, chronic inflammation-এর chance বাড়তে পারে।
  • তবে circumcision নিজে একমাত্র factor নয়; hygiene, HPV exposure, smoking, immune status—সবকিছু মিলে risk নির্ধারণ করে।

Related cancer

  • Penile squamous cell carcinoma

23. HIV infection

কীভাবে risk বাড়ে?

  • HIV immune surveillance কমায়।
  • HPV persistence বাড়ায়।
  • Precancerous lesion progression দ্রুত হতে পারে।
  • Penile, cervical, vulvar, vaginal, anal cancer risk বাড়তে পারে।

American Cancer Society penile cancer risk factor হিসেবে HIV infection উল্লেখ করেছে।

24. Cryptorchidism / undescended testis

Mainly testicular cancer

কী?

Testis যদি জন্মের পরে scrotum-এ নেমে না আসে, তাকে cryptorchidism বলে।

কীভাবে risk বাড়ে?

  • Abdomen/inguinal canal-এর higher temperature germ cell development disturb করে।
  • Abnormal germ cell maturation → carcinoma in situ → testicular germ cell tumour হতে পারে।
  • Orchiopexy করলে risk কমতে পারে, কিন্তু পুরোপুরি normal হয় না।

American Cancer Society undescended testicle-কে testicular cancer-এর main risk factor হিসেবে উল্লেখ করেছে।

25. Previous testicular cancer

কীভাবে risk বাড়ে?

  • এক testis-এ cancer থাকলে opposite testis-এও germ cell abnormality থাকতে পারে।
  • Shared genetic/developmental risk থাকে।
  • তাই long-term follow-up দরকার।

Cancer Australia testicular cancer risk factors-এর মধ্যে previous testicular cancer, family history, abnormal testicle development ও undescended testicle উল্লেখ করেছে।

26. Abnormal testicular development / infertility-related factors

কীভাবে risk বাড়ে?

  • Testicular dysgenesis syndrome concept অনুযায়ী fetal life-এ testicular development abnormal হলে later infertility, cryptorchidism, hypospadias ও testicular cancer risk বাড়তে পারে।
  • Germ cell maturation defect cancer pathway তৈরি করতে পারে।

Related cancer

  • Testicular germ cell tumour

27. Age

Age অনেক genital cancer-এর major risk factor।

Organ-wise

  • Cervical cancer: সাধারণত middle age; screening না থাকলে later detected হয়।
  • Vulvar cancer: older age বেশি।
  • Endometrial cancer: postmenopausal age common।
  • Ovarian cancer: age বাড়লে risk বাড়ে।
  • Prostate cancer: 50 বছরের পর risk বেশি।
  • Testicular cancer: young adult male—15–40 বছর common pattern।
  • Penile cancer: older age বেশি।

NCI prostate cancer prevention summary age-কে prostate cancer risk factor হিসেবে উল্লেখ করেছে।

28. Race / ethnicity / population factor

এটা biological + social + healthcare access মিলিয়ে complex factor।

Examples

  • Prostate cancer risk certain populations-এ বেশি দেখা যায়।
  • Testicular cancer white men-এ বেশি common।
  • Cervical cancer low-resource settings-এ বেশি, কারণ HPV vaccination ও screening কম।

CDC prostate cancer risk factor page age এবং increased-risk groups উল্লেখ করে।

29. Radiation exposure / previous pelvic radiation

কীভাবে risk বাড়ে?

  • Ionizing radiation DNA damage করে।
  • Long latency period পরে secondary malignancy হতে পারে।
  • Previous pelvic radiotherapy-এর history থাকলে uterine/vaginal/pelvic malignancy risk consider করতে হয়।

Related cancers

  • Uterine sarcoma
  • Vaginal cancer
  • Secondary pelvic malignancy

30. Diet, physical inactivity, metabolic health

Mainly endometrial/prostate-related risk context

  • High calorie diet → obesity → estrogen/insulin pathway activation।
  • Physical inactivity → obesity, insulin resistance, chronic inflammation।
  • Excess dairy/calcium association prostate cancer literature-এ discussed, কিন্তু সব evidence uniform নয়।

NCI prostate cancer prevention summary dairy/calcium, folic acid, vitamin E, hormones, age ও family history risk factor হিসেবে আলোচনা করেছে।

Organ-wise Shortcut Cause List

Cervical cancer

  • Persistent high-risk HPV 16/18
  • Early sexual activity
  • Multiple sexual partners
  • Smoking
  • HIV/immunosuppression
  • Other STI
  • High parity
  • Young age at first pregnancy
  • Long-term hormonal contraceptive use
  • No cervical screening

Vulvar cancer

  • HPV infection
  • Vulvar intraepithelial neoplasia
  • Smoking
  • Lichen sclerosus
  • Chronic vulvar itching/inflammation
  • Older age
  • Immunosuppression

Vaginal cancer

  • HPV infection
  • Previous cervical cancer/CIN
  • Vaginal intraepithelial neoplasia
  • Smoking
  • Immunosuppression
  • Older age

Endometrial / uterine cancer

  • Unopposed estrogen
  • Obesity
  • PCOS/anovulation
  • Nulliparity
  • Early menarche/late menopause
  • Diabetes/metabolic syndrome
  • Tamoxifen
  • Lynch syndrome
  • Estrogen-only HRT

Ovarian / fallopian tube cancer

  • BRCA1/BRCA2 mutation
  • Family history of ovarian/breast cancer
  • Lynch syndrome
  • Increasing age
  • Endometriosis
  • Obesity
  • Postmenopausal hormone therapy
  • Nulliparity/infertility-related factors

Penile cancer

  • HPV infection
  • Phimosis
  • Poor genital hygiene
  • Chronic balanitis/inflammation
  • Smoking/tobacco
  • HIV/immunosuppression
  • Older age
  • Lichen sclerosus

Testicular cancer

  • Cryptorchidism
  • Previous testicular cancer
  • Family history
  • Abnormal testicular development
  • Testicular dysgenesis
  • Young adult age group

Prostate cancer

  • Increasing age
  • Family history
  • Genetic mutation such as BRCA2
  • Androgen-related biology
  • Race/population risk
  • Obesity/metabolic syndrome may worsen aggressive disease risk/prognosis

Overview / Summary

Genital cancers-এর cause একক নয়। HPV infection cervical, vulvar, vaginal ও penile cancer-এর প্রধান preventable cause। Endometrial cancer মূলত unopposed estrogen, obesity, PCOS, diabetes, Lynch syndrome-এর সাথে related। Ovarian cancer-এ BRCA mutation, family history, endometriosis ও age গুরুত্বপূর্ণ। Penile cancer-এ HPV, phimosis, poor hygiene, smoking গুরুত্বপূর্ণ। Testicular cancer-এ cryptorchidism সবচেয়ে important risk factor। Prostate cancer-এ age, family history, androgen biology ও genetic risk বেশি গুরুত্বপূর্ণ।

Actionable Plan / Steps

  1. HPV vaccine নিতে হবে eligible age group-এ।
  2. Cervical screening করতে হবে: HPV DNA / Pap smear / VIA according to local program.
  3. Postmenopausal bleeding হলে endometrial biopsy consider করতে হবে।
  4. Non-healing genital ulcer/lump হলে biopsy delay করা যাবে না।
  5. Testicular painless lump হলে urgent scrotal ultrasound + tumour marker করতে হবে।
  6. Strong family history থাকলে BRCA/Lynch genetic counselling consider করতে হবে।
  7. Smoking cessation, safe sex, condom use, genital hygiene, weight control—সবগুলো prevention-এ গুরুত্বপূর্ণ।

3. Symptoms / Clinical Features — লক্ষণগুলো

A. Cervical cancer

  • Intermenstrual bleeding
  • Postcoital bleeding
  • Postmenopausal bleeding
  • Foul-smelling vaginal discharge
  • Pelvic pain
  • Advanced stage: leg swelling, urinary obstruction, back pain, weight loss

B. Vulvar cancer

  • Vulvar itching দীর্ঘদিন
  • Vulvar lump/ulcer
  • Pain, burning
  • Bleeding or discharge
  • Skin colour change, thickened plaque

C. Vaginal cancer

  • Painless vaginal bleeding
  • Postcoital bleeding
  • Watery/foul discharge
  • Dyspareunia
  • Pelvic pain

D. Endometrial / uterine cancer

  • Postmenopausal bleeding = red flag
  • Heavy/irregular bleeding
  • Watery discharge
  • Pelvic pain
  • Advanced: weight loss, anemia

E. Ovarian / fallopian tube cancer

  • Abdominal bloating
  • Early satiety
  • Pelvic/abdominal pain
  • Increased abdominal girth
  • Urinary frequency
  • Constipation
  • Often late diagnosis because symptoms nonspecific

F. Penile cancer

  • Non-healing penile ulcer
  • Growth/lump on glans/prepuce
  • Bleeding, discharge
  • Foul smell
  • Phimosis
  • Inguinal lymph node swelling

G. Testicular cancer

  • Painless testicular lump
  • Testicular heaviness
  • Dull ache lower abdomen/scrotum
  • Gynecomastia sometimes
  • Back pain if retroperitoneal lymph node spread

H. Prostate cancer

  • LUTS: frequency, urgency, nocturia, weak stream
  • Hematuria/hematospermia
  • Bone pain in metastasis
  • Weight loss, anemia in advanced disease

Genital cancers-এর Symptoms — বিস্তারিত বাংলা ব্যাখ্যা

Core meaning: Genital cancer-এর symptom অনেক সময় শুরুতে খুব কম বা অস্পষ্ট থাকে। তাই অস্বাভাবিক bleeding, non-healing ulcer/lump, persistent pelvic pain, abdominal bloating, urinary difficulty, painless testicular lump—এগুলোকে red flag ধরে evaluate করতে হয়।

1. Female genital cancers-এর common warning symptoms

CDC অনুযায়ী gynecologic cancers-এ abnormal vaginal bleeding/discharge common warning sign; ovarian cancer-এ bloating, early satiety, abdominal/back pain বেশি দেখা যায়; uterine/ovarian cancer-এ pelvic pain/pressure এবং ovarian/vaginal cancer-এ urinary urgency/constipation হতে পারে।

A. Abnormal vaginal bleeding — সবচেয়ে গুরুত্বপূর্ণ warning sign

কী ধরনের bleeding suspicious?

  • মাসিকের মাঝখানে bleeding
  • সহবাসের পরে bleeding — postcoital bleeding
  • menopause-এর পরে সামান্য spotting হলেও
  • মাসিক অতিরিক্ত heavy হওয়া
  • মাসিক দীর্ঘদিন চলা
  • pelvic examination-এর পরে repeated bleeding
  • watery blood-stained discharge

কেন হয়?

Cancer cervix, endometrium, vagina বা vulva-এর tissue fragile করে ফেলে। ফলে সামান্য friction বা spontaneous tissue breakdown থেকেও bleeding হয়।

কোন cancer-এ বেশি দেখা যায়?

  • Cervical cancer
  • Endometrial cancer
  • Vaginal cancer
  • Vulvar cancer
  • Advanced ovarian cancer-এও abnormal bleeding হতে পারে

Postmenopausal bleeding endometrial cancer-এর classic symptom; একটি large systematic review/meta-analysis-এ endometrial cancer diagnosed নারীদের প্রায় 90% postmenopausal bleeding report করেছিলেন।

B. Abnormal vaginal discharge

কেমন discharge suspicious?

  • পানির মতো watery discharge
  • দুর্গন্ধযুক্ত discharge
  • blood-mixed discharge
  • brownish বা pinkish discharge
  • দীর্ঘদিন ধরে persistent discharge
  • antibiotic/antifungal নেওয়ার পরও না কমা discharge

কেন হয়?

Tumour tissue necrosis, secondary infection, ulceration এবং cervical/vaginal gland involvement-এর কারণে watery বা foul-smelling discharge হয়।

কোন cancer-এ বেশি?

  • Cervical cancer
  • Vaginal cancer
  • Endometrial cancer
  • Advanced vulvar cancer

NCI cervical cancer symptom হিসেবে watery, strong odorযুক্ত বা blood-containing discharge, pelvic pain ও sex-এর সময় pain উল্লেখ করেছে।

C. Pelvic pain / pelvic pressure

রোগী কীভাবে বলে?

  • তলপেটে চাপ লাগে
  • কোমর/পেলভিসে dull ache
  • মাসিক ব্যথার মতো ব্যথা, কিন্তু মাসিকের সাথে related না
  • sex-এর সময় deep pain
  • long-standing pelvic heaviness

কেন হয়?

Tumour pelvic nerve, uterus, cervix, ovary, bladder বা bowel-এর উপর pressure দিলে pain হয়। Locally advanced cancer pelvic wall বা nerve plexus involve করলে pain বেশি severe হয়।

কোন cancer-এ বেশি?

  • Cervical cancer
  • Ovarian cancer
  • Endometrial cancer
  • Vaginal cancer

D. Pain during intercourse — dyspareunia

কী বোঝায়?

সহবাসের সময় নতুন করে pain হওয়া, deep pelvic pain, bleeding সহ pain—এসব suspicious।

কেন হয়?

Cervical lesion, vaginal wall tumour, vulvar ulcer, pelvic mass, inflammation অথবা radiation/surgical scar থাকলে pain হতে পারে।

কোন cancer?

  • Cervical cancer
  • Vaginal cancer
  • Vulvar cancer
  • Advanced pelvic malignancy

2. Cervical cancer symptoms — জরায়ুমুখের ক্যান্সার

Early cervical cancer অনেক সময় asymptomatic থাকে। Symptoms দেখা দিলে সাধারণত lesion বড় হয় বা local tissue involve করে। Mayo Clinic-ও উল্লেখ করেছে early cervical cancer সাধারণত symptom দেয় না; progressed হলে abnormal bleeding, watery/bloody foul discharge ও pelvic pain হতে পারে।

Main symptoms

1. Postcoital bleeding

  • সহবাসের পরে bleeding হয়।
  • Cervical tumour খুব friable হয়, তাই contact bleeding হয়।
  • এটা cervical cancer-এর classic warning sign।

2. Intermenstrual bleeding

  • মাসিকের মাঝখানে bleeding।
  • Cervix বা endometrium থেকে abnormal bleeding হতে পারে।

3. Postmenopausal bleeding

  • menopause-এর পরে যেকোনো bleeding abnormal।
  • Cervical বা endometrial cancer exclude করতে হয়।

4. Foul-smelling watery discharge

  • Tumour necrosis ও infection হলে দুর্গন্ধ হয়।
  • Blood-mixed watery discharge cervical malignancy-তে suspicious।

5. Pelvic pain / back pain

  • Early stage-এ কম।
  • Parametrial, pelvic wall বা nerve involvement হলে pain বাড়ে।

6. Pain during sex

  • Cervical lesion trauma পেলে pain/bleeding হয়।

7. Advanced symptoms

  • Leg swelling — lymphatic/venous obstruction
  • Urinary obstruction — ureter involvement
  • Hematuria — bladder invasion
  • Rectal bleeding — rectal invasion
  • Weight loss, fatigue, anemia

3. Endometrial / uterine cancer symptoms — জরায়ুর ভিতরের স্তরের ক্যান্সার

Endometrial cancer সাধারণত early symptom দেয়, তাই early diagnosis তুলনামূলক বেশি হয়। Mayo Clinic বলছে irregular vaginal bleeding often first symptom।

Main symptoms

1. Postmenopausal bleeding — সবচেয়ে important

  • menopause-এর পরে এক ফোঁটা spotting হলেও suspicious।
  • Bleeding watery, pinkish, brownish বা frank red হতে পারে।
  • Endometrial cancer exclude না করা পর্যন্ত এটাকে normal বলা যাবে না।

2. Heavy or prolonged menstrual bleeding

  • 40 বছরের বেশি বয়সে নতুন করে heavy bleeding হলে evaluate করতে হবে।
  • Fibroid, adenomyosis, hormonal problem হতে পারে, কিন্তু endometrial pathology exclude দরকার।

3. Irregular cycle

  • অনিয়মিত bleeding, frequent bleeding, spotting।
  • Especially obesity/PCOS/diabetes থাকলে বেশি suspicious।

4. Watery vaginal discharge

  • Postmenopausal woman-এ watery/clear discharge suspicious হতে পারে।

5. Pelvic cramping or lower abdominal pain

  • Tumour বড় হলে uterus distension, cervical stenosis বা pelvic spread থেকে pain হতে পারে।

6. Advanced symptoms

  • Weight loss
  • Anemia
  • Pelvic mass
  • Leg swelling
  • Bowel/bladder symptoms

4. Ovarian / fallopian tube cancer symptoms — ডিম্বাশয়/ফ্যালোপিয়ান টিউব ক্যান্সার

Ovarian cancer-এর symptoms অনেক সময় vague—gastric problem, IBS, UTI ভেবে miss হয়। Ovarian cancer symptom index গবেষণায় pelvic/abdominal pain, urinary urgency/frequency, increased abdominal size/bloating, difficulty eating/feeling full উল্লেখযোগ্যভাবে ovarian cancer-এর সাথে associated ছিল।

Main symptoms

1. Persistent abdominal bloating

  • পেট সবসময় ফাঁপা লাগে।
  • খাবারের কারণে আসে-যায় না; অনেকদিন ধরে থাকে।
  • Ascites বা tumour mass-এর কারণে abdominal distension হয়।

2. Early satiety

  • অল্প খেয়েই পেট ভরে যায়।
  • Tumour/ascites stomach-এর উপর pressure দেয়।

3. Loss of appetite

  • খাবারে অরুচি।
  • Often gastric problem মনে হয়।

4. Pelvic or abdominal pain

  • তলপেটে চাপ, dull pain, heaviness।
  • Tumour ovary, peritoneum বা pelvic organ involve করলে হয়।

5. Increased abdominal girth

  • পেটের মাপ বাড়ে।
  • কাপড় tight লাগে।
  • Ascites বা large ovarian mass-এর কারণে।

6. Urinary frequency/urgency

  • বারবার প্রস্রাব লাগে।
  • Bladder-এর উপর tumour pressure পড়ে।
  • UTI-এর মতো মনে হতে পারে, কিন্তু burning usually prominent না-ও হতে পারে।

7. Bowel habit change

  • Constipation
  • Diarrhea
  • incomplete evacuation feeling
  • Bowel pressure বা peritoneal disease-এর কারণে।

8. Back pain / fatigue / weight loss

  • Advanced stage-এ বেশি।
  • Cachexia, anemia, metastatic disease হতে পারে।

9. Acute severe pain

  • Ovarian torsion, rupture বা bleeding হলে sudden severe pain হতে পারে।
  • Emergency evaluation দরকার।

Ovarian cancer awareness guidance-এ persistent bloating, early satiety, urinary frequency/urgency এবং tummy/pelvic pain প্রধান symptom হিসেবে উল্লেখ করা হয়।

5. Vulvar cancer symptoms — বাহ্যিক যৌনাঙ্গের ক্যান্সার

Vulvar cancer অনেক সময় chronic itching বা skin disease হিসেবে শুরু হয়, তাই patient দেরিতে আসে।

Main symptoms

1. Persistent vulvar itching

  • দীর্ঘদিন ধরে চুলকানি।
  • Antifungal/steroid cream ব্যবহার করেও পুরোপুরি ভালো হয় না।
  • Lichen sclerosus বা VIN থেকে cancer develop হতে পারে।

2. Vulvar lump / thickened skin

  • labia/clitoris/perineal area-এ শক্ত অংশ।
  • Skin thick, rough বা raised হতে পারে।

3. Non-healing ulcer

  • ঘা শুকায় না।
  • মাঝে মাঝে bleeding হয়।
  • Painful বা painless দুইটাই হতে পারে।

4. Skin colour change

  • white patch
  • red patch
  • dark/brown patch
  • wart-like growth

5. Burning pain

  • প্রস্রাব লাগলে জ্বালা।
  • Ulcerated lesion urine contact করলে pain হয়।

6. Bleeding or discharge

  • Lesion breakdown হলে bleeding/discharge হয়।

7. Groin lymph node swelling

  • Inguinal node spread হলে কুঁচকিতে lump হতে পারে।

6. Vaginal cancer symptoms — যোনিপথের ক্যান্সার

Vaginal cancer early stage-এ symptom নাও দিতে পারে। Cleveland Clinic অনুযায়ী vaginal cancer-এ vaginal bleeding after sex/menopause, watery/bloody/foul discharge, painful sex, vaginal mass, urinary symptoms, constipation ও pelvic pain হতে পারে।

Main symptoms

1. Bleeding after sex

  • Vaginal wall tumour friction-এ bleed করে।

2. Postmenopausal bleeding

  • menopause-এর পরে vaginal bleeding সবসময় abnormal।

3. Watery/bloody/foul discharge

  • Tumour necrosis বা infection থেকে।

4. Pain during sex

  • Vaginal wall lesion, ulceration বা narrowing থেকে।

5. Vaginal mass feeling

  • রোগী vaginal canal-এ lump বা obstruction অনুভব করতে পারে।

6. Painful urination / urinary frequency

  • Anterior vaginal wall বা bladder-adjacent tumour হলে।

7. Constipation / rectal pressure

  • Posterior vaginal wall বা rectal pressure হলে।

8. Pelvic pain

  • Advanced local spread-এর sign।

7. Penile cancer symptoms — লিঙ্গের ক্যান্সার

Penile cancer অনেক সময় glans বা foreskin-এর নিচে শুরু হয়। American Cancer Society penile cancer signs হিসেবে skin thickening, colour change, lump, bleeding ulcer, reddish velvety rash, crusty bumps, bluish-brown growths, smelly discharge বা bleeding under foreskin উল্লেখ করেছে।

Main symptoms

1. Non-healing penile ulcer

  • লিঙ্গে ঘা হয়, শুকায় না।
  • মাঝে মাঝে bleeding করে।
  • Pain না থাকলেও cancer হতে পারে।

2. Lump or growth

  • Glans/foreskin/shaft-এ small lump।
  • Wart-like বা cauliflower-like growth হতে পারে।

3. Skin colour change

  • red patch
  • white patch
  • bluish-brown patch
  • thickened skin

4. Foul-smelling discharge under foreskin

  • Phimosis থাকলে foreskin-এর নিচে discharge জমে।
  • Tumour ulceration ও infection থেকে দুর্গন্ধ হয়।

5. Bleeding

  • Ulcerated tumour থেকে bleeding।

6. Pain or burning

  • Early stage-এ pain নাও থাকতে পারে।
  • Infection/ulceration হলে pain হয়।

7. Phimosis worsening

  • foreskin টানা যায় না।
  • Cancer লুকিয়ে থাকতে পারে।

8. Inguinal lymph node swelling

  • কুঁচকিতে শক্ত lymph node।
  • Penile cancer lymphatic spread-এর important sign।

8. Testicular cancer symptoms — অণ্ডকোষের ক্যান্সার

Testicular cancer-এর সবচেয়ে common symptom হলো painless testicular lump। NCI testicular cancer symptom হিসেবে painless lump/swelling, testicle feel change, lower abdomen/groin dull ache, sudden scrotal fluid build-up এবং testicular/scrotal pain উল্লেখ করেছে।

Main symptoms

1. Painless testicular lump

  • সাধারণত এক testis-এ।
  • ব্যথা না থাকায় অনেক রোগী ignore করে।
  • Hard, irregular lump suspicious।

2. Testicular swelling

  • testis বড় হয়ে যাওয়া।
  • Hydrocele ভেবে ভুল হতে পারে।

3. Scrotal heaviness

  • scrotum heavy বা dragging sensation।
  • Tumour mass effect।

4. Dull ache in lower abdomen/groin

  • Retroperitoneal lymph node spread বা cord involvement হতে পারে।

5. Sudden fluid collection

  • Scrotum হঠাৎ ফুলে যাওয়া।
  • Reactive hydrocele হতে পারে।

6. Pain or discomfort

  • বেশিরভাগ painless, কিন্তু pain থাকলেও cancer exclude করা যায় না।

7. Breast tenderness/gynecomastia

  • কিছু germ cell tumour β-hCG produce করে hormonal effect দিতে পারে।

8. Back pain

  • Retroperitoneal lymph node metastasis হলে।

9. Advanced symptoms

  • Cough/shortness of breath — lung metastasis
  • Weight loss
  • Fatigue
  • Neck node swelling rare

9. Prostate cancer symptoms — প্রোস্টেট ক্যান্সার

Prostate cancer early stage-এ প্রায়ই asymptomatic থাকে। CDC prostate cancer symptom হিসেবে difficulty starting urination, weak/interrupted stream, frequent nocturnal urination, incomplete emptying, dysuria, blood in urine/semen, persistent back/hip/pelvic pain ও painful ejaculation উল্লেখ করেছে।

Main symptoms

1. Difficulty starting urination

  • প্রস্রাব শুরু করতে সময় লাগে।
  • Prostate urethra compress করলে হয়।

2. Weak urine stream

  • প্রস্রাবের গতি কমে যায়।
  • Stream interrupted হতে পারে।

3. Frequency and nocturia

  • বারবার প্রস্রাব লাগে।
  • রাতে বারবার উঠতে হয়।

4. Incomplete emptying

  • প্রস্রাব শেষ হওয়ার পরও bladder ভরা মনে হয়।

5. Urgency

  • হঠাৎ প্রস্রাবের চাপ আসে।

6. Blood in urine or semen

  • Hematuria বা hematospermia red flag।
  • Cancer ছাড়াও prostatitis/BPH/stone হতে পারে, কিন্তু evaluation দরকার।

7. Painful ejaculation / erectile dysfunction

  • Advanced local disease বা associated prostate pathology থাকতে পারে।

8. Bone pain

  • Prostate cancer commonly bone metastasis করতে পারে।
  • Back, hip, pelvis, ribs-এ persistent pain suspicious।

9. Weight loss / fatigue

  • Advanced malignancy, anemia বা metastatic disease-এর sign।

10. Symptoms by stage — সহজভাবে

Early stage symptoms

  • অনেক সময় কোনো symptom নেই
  • abnormal bleeding
  • mild discharge
  • small lump/ulcer
  • mild pelvic discomfort
  • painless testicular lump

Locally advanced symptoms

  • severe pelvic pain
  • foul discharge
  • heavy bleeding
  • urinary obstruction
  • constipation
  • groin lymph node
  • leg swelling

Metastatic symptoms

  • unexplained weight loss
  • severe fatigue
  • bone pain
  • ascites
  • shortness of breath
  • persistent back pain
  • jaundice/liver symptoms
  • anemia

11. Red flag symptoms — urgent referral দরকার

  1. Menopause-এর পরে যেকোনো vaginal bleeding
  2. Sex-এর পরে repeated bleeding
  3. Watery/foul-smelling blood-mixed discharge
  4. Non-healing genital ulcer > 2–3 weeks
  5. Vulvar itching/skin change দীর্ঘদিন
  6. Persistent abdominal bloating + early satiety
  7. Pelvic pain/pressure নতুন করে শুরু হয়ে weeks ধরে থাকা
  8. Painless testicular lump
  9. Penile ulcer/lump + foul discharge
  10. Blood in urine/semen + urinary difficulty
  11. Persistent back/hip/pelvic bone pain in older male
  12. Groin lymph node swelling

12. Differential reminder — সব symptom cancer নয়

এই symptoms infection, fibroid, polyp, endometriosis, adenomyosis, PCOS, UTI, STI, prostatitis, BPH, hydrocele, epididymo-orchitis, genital wart, lichen sclerosus থেকেও হতে পারে। কিন্তু persistent, recurrent, unexplained, postmenopausal, bleeding-associated, non-healing, painless hard lump হলে cancer exclude করা জরুরি।

Overview / Summary

Genital cancer-এর symptoms organ অনুযায়ী আলাদা। Female genital cancer-এ সবচেয়ে গুরুত্বপূর্ণ warning হলো abnormal vaginal bleeding/discharge, pelvic pain, dyspareunia, bloating, early satiety। Male genital cancer-এ important warning হলো penile non-healing ulcer/lump, foul discharge, painless testicular lump, urinary obstruction, blood in urine/semen, bone pain। Early stage-এ symptom না থাকলেও suspicious symptom থাকলে biopsy/imaging delay করা যাবে না।

Actionable Plan / Steps

  1. Postmenopausal bleeding → urgent gynecology referral + endometrial/cervical evaluation।
  2. Postcoital bleeding → speculum exam + Pap/HPV/colposcopy as indicated।
  3. Persistent bloating + early satiety + pelvic pain → pelvic US + CA-125 consideration।
  4. Vulvar/penile non-healing ulcer → biopsy।
  5. Painless testicular lump → urgent scrotal US + AFP/β-hCG/LDH।
  6. Male urinary symptoms + blood in urine/semen/bone pain → PSA, DRE, urology referral।
  7. Symptoms >2–3 weeks বা recurrent হলে self-medication না করে clinical examination।

4. Clinical Diagnosis & Investigations — নির্দিষ্টভাবে

A. Clinical examination

  1. History
    • Bleeding pattern, discharge, pelvic pain
    • Sexual history, HPV vaccination, Pap/HPV screening history
    • Smoking, HIV/immunosuppression
    • Family history: breast/ovarian/endometrial/colon cancer
  2. General examination
    • Pallor, cachexia, lymph nodes
    • Abdomen: mass, ascites
    • Bone tenderness if prostate metastasis suspected
  3. Local genital examination
    • Speculum examination
    • Bimanual pelvic examination
    • Rectovaginal examination for parametrial involvement
    • Penile/scrotal examination
    • Digital rectal examination for prostate

B. Cancer-specific investigations

Cervical cancer

  • Pap smear / liquid-based cytology
  • HPV DNA testing
  • Colposcopy
  • Cervical punch biopsy
  • Endocervical curettage if indicated
  • MRI pelvis for local staging
  • CT chest/abdomen/pelvis or PET-CT for metastasis
  • Cystoscopy/proctoscopy if bladder/rectal invasion suspected
    NCI lists cervical cancer treatment/workup based on surgery, radiation, chemotherapy, targeted therapy and immunotherapy depending on stage.

Vulvar cancer

  • Careful vulvar inspection
  • Punch/wedge biopsy
  • Inguinal lymph node assessment
  • MRI pelvis/CT/PET-CT for advanced disease
    Vulvar cancer treatment commonly includes surgery, radiotherapy, chemoradiotherapy, topical imiquimod in selected preinvasive disease, and systemic therapy in advanced/recurrent cases.

Vaginal cancer

  • Speculum exam
  • Colposcopy
  • Biopsy
  • MRI pelvis
  • CT/PET-CT for nodal/distant disease
    Radiation therapy is commonly used for stage II–IVA vaginal cancer; advanced/recurrent cases may follow cervical cancer regimens, although evidence is limited.

Endometrial cancer

  • Transvaginal ultrasound: endometrial thickness
  • Endometrial biopsy / Pipelle biopsy
  • Hysteroscopy-directed biopsy
  • MRI pelvis for myometrial/cervical invasion
  • CT chest/abdomen/pelvis for advanced disease
  • MMR/MSI testing, p53, POLE if available
    NCI includes surgery, chemotherapy, radiation, targeted therapy and immunotherapy in endometrial cancer depending on stage and molecular subtype.

Ovarian / fallopian tube cancer

  • Pelvic exam
  • TVS + abdominal ultrasound
  • CA-125; HE4/ROMA where available
  • CT abdomen/pelvis/chest
  • Ascitic fluid cytology if ascites
  • Surgical staging biopsy
  • BRCA1/2 and HRD testing where possible
    Ovarian/fallopian tube/primary peritoneal cancer treatment includes surgery, chemotherapy, targeted therapy and PARP inhibitors in selected patients.

Penile cancer

  • Inspection of lesion
  • Biopsy from lesion
  • Palpation of inguinal nodes
  • Ultrasound-guided FNAC/biopsy of nodes
  • MRI penis/pelvis if local invasion unclear
  • CT/PET-CT for nodal/distant spread
    NCI notes HPV as a risk factor; diagnosis needs examination and biopsy, followed by staging tests.

Testicular cancer

  • Scrotal ultrasound
  • Tumour markers: AFP, β-hCG, LDH
  • Radical inguinal orchiectomy for diagnosis/treatment
  • CT abdomen/pelvis/chest for staging
  • Semen preservation before chemotherapy
    BEP regimen—bleomycin, etoposide, cisplatin for 3 cycles—is a standard option for good-risk metastatic germ cell tumour; EP for 4 cycles is used when bleomycin is contraindicated.

Prostate cancer

  • PSA
  • Digital rectal examination
  • Multiparametric MRI prostate
  • TRUS/MRI-fusion biopsy
  • Gleason grade group
  • Bone scan / PSMA PET-CT where available
  • CT/MRI for nodal disease
    NCI lists ADT, LHRH agonist therapy, antiandrogen therapy, abiraterone, orchiectomy and other approaches for prostate cancer.

5. Complications — রোগের জটিলতা

  • Local invasion: bladder, rectum, urethra, pelvic wall invasion হতে পারে।
  • Bleeding & anemia: chronic genital bleeding থেকে severe anemia হতে পারে।
  • Obstructive uropathy: cervical/prostate/penile cancer ureter or urethra block করতে পারে।
  • Fistula: advanced cervical/vaginal cancer → vesicovaginal বা rectovaginal fistula.
  • Lymphedema: pelvic/inguinal node involvement or surgery/radiation-এর পরে leg/genital swelling.
  • Infertility/sexual dysfunction: surgery, radiation, chemotherapy fertility ও sexual function নষ্ট করতে পারে।
  • Metastasis: lymph node, lung, liver, bone, peritoneum.
  • Ascites & bowel obstruction: ovarian cancer-এ common advanced complication.
  • Psychological impact: depression, anxiety, body image disturbance.
  • Treatment toxicity: myelosuppression, renal toxicity, neuropathy, menopause, cardiotoxicity, immunotherapy-related autoimmune complications.

6. Treatment Management — Guideline-based overview

General principle

  1. Pre-cancer / early lesion: excision, LEEP/conization, local therapy.
  2. Early invasive localized cancer: surgery ± lymph node assessment.
  3. Locally advanced cancer: chemoradiotherapy.
  4. Metastatic/recurrent cancer: systemic chemotherapy ± targeted therapy ± immunotherapy.
  5. Palliative care: pain control, bleeding control, obstruction relief, nutrition, psychosocial support.

Cancer-specific core treatment

Cervical cancer

  • CIN / carcinoma in situ: LEEP, cold-knife conization, ablative therapy if appropriate.
  • Early stage: radical hysterectomy + pelvic lymph node assessment or fertility-sparing trachelectomy in selected cases.
  • Locally advanced: external beam radiation + brachytherapy + weekly cisplatin.
  • Recurrent/metastatic: platinum + paclitaxel ± bevacizumab ± pembrolizumab depending on PD-L1/MSI/MMR and eligibility. Concurrent cisplatin-based chemoradiotherapy improves survival in locally advanced cervical cancer.

Vulvar cancer

  • Early: wide local excision / radical local excision + sentinel/inguinal node assessment.
  • Locally advanced: surgery ± radiation; chemoradiation if unresectable.
  • Vulvar HSIL/preinvasive selected lesion: imiquimod may be used under specialist care.
  • Recurrent: excision, radiation/chemoradiation, systemic therapy.

Vaginal cancer

  • Early small lesion: surgery or radiation.
  • Stage II–IVA: radiation ± cisplatin/5-FU-based chemotherapy.
  • Stage IVB/recurrent: palliative radiation; systemic therapy often extrapolated from cervical cancer.

Endometrial cancer

  • Standard early: total hysterectomy + bilateral salpingo-oophorectomy ± sentinel/pelvic node assessment.
  • High-risk/advanced: surgery + carboplatin/paclitaxel ± radiation.
  • Advanced/recurrent: carboplatin + paclitaxel ± pembrolizumab/dostarlimab depending on MMR/MSI and protocol.
  • pMMR recurrent disease: pembrolizumab + lenvatinib option in many guidelines.

Ovarian/fallopian tube cancer

  • Surgical staging/debulking.
  • Adjuvant carboplatin + paclitaxel usually 6 cycles.
  • BRCA/HRD positive: PARP inhibitor maintenance such as olaparib.
  • Recurrent platinum-sensitive: platinum-based combination ± bevacizumab/PARP depending on previous therapy.

Penile cancer

  • Early: organ-preserving surgery, laser/topical therapy for selected superficial lesions.
  • Invasive: partial/total penectomy depending on tumour extent.
  • Node-positive: inguinal lymph node dissection ± chemotherapy/radiation.
  • Advanced: cisplatin-based combination chemotherapy/palliation.

Testicular cancer

  • Radical inguinal orchiectomy first.
  • Seminoma: surveillance/radiation/carboplatin/chemotherapy depending on stage.
  • Nonseminoma/metastatic: BEP x 3 cycles or EP x 4 cycles if bleomycin contraindicated.

Prostate cancer

  • Localized low risk: active surveillance or surgery/radiotherapy.
  • Localized intermediate/high risk: radical prostatectomy or radiotherapy + ADT.
  • Metastatic hormone-sensitive: ADT + docetaxel/abiraterone/enzalutamide/apalutamide depending on fitness and availability.
  • Castration-resistant: abiraterone, docetaxel, cabazitaxel, PARP inhibitor in selected mutation-positive cases.

7. Pharmacological Drugs — Bangladesh available brands সহ

Note: Brand availability/prices change frequently. নিচের brand list MedEx Bangladesh–এ listed available brands থেকে নেওয়া; market stock/DGDA registration clinically verify করতে হবে।

1. Generic name: Cisplatin

  • Therapeutic category: Anticancer chemotherapy
  • Pharmacological class: Platinum coordination compound
  • Bangladesh available brand name: Cesalin 1 mg/ml, Cisplat 1 mg/ml, Cisplatin 1 mg/ml, Cisplatin Hexal 1 mg/ml, Cisplatin PhaRes 1 mg/ml, Cistor 1 mg/ml, Neoplat 1 mg/ml, Platinex 1 mg/ml, Platosin 1 mg/ml, Renaplat 1 mg/ml, Sinplatin 1 mg/ml; common vials 10 mg, 50 mg.
  • Purpose: Cervical chemoradiation, penile cancer, testicular BEP/EP, other platinum-sensitive cancers.
  • Dose example: Cervical CCRT: 40 mg/m² IV weekly during radiation, usually 5–6 weeks. Testicular BEP: 20 mg/m² IV days 1–5 every 21 days.
  • Side effects: Nephrotoxicity, ototoxicity, severe nausea/vomiting, neuropathy, myelosuppression, electrolyte loss Mg/K.
  • Important interactions: Aminoglycosides, amphotericin B, NSAIDs, loop diuretics → renal/ototoxicity risk; live vaccines avoid.

2. Generic name: Carboplatin

  • Therapeutic category: Anticancer chemotherapy
  • Pharmacological class: Platinum analogue
  • Bangladesh available brand name: Carboplat 10 mg/ml, Carboplatin 10 mg/ml, Carboplatin Sindan, Carboplatin Hexal, Carboplatin PhaRes, Carbotin, Carbotor, Carplatin, Cytocarb, Renacarb; common vials 150 mg, 450 mg, 800 mg.
  • Purpose: Ovarian/endometrial first-line with paclitaxel; cervical if cisplatin unsuitable.
  • Dose example: AUC 5–6 IV day 1 every 21 days with paclitaxel, usually 6 cycles.
  • Side effects: Thrombocytopenia, neutropenia, nausea, renal toxicity less than cisplatin, hypersensitivity.
  • Interactions: Other myelosuppressive drugs, nephrotoxic drugs, live vaccines.

3. Generic name: Paclitaxel

  • Therapeutic category: Anticancer chemotherapy
  • Pharmacological class: Taxane; microtubule inhibitor
  • Bangladesh available brand name: Paclitaxel 6 mg/ml, Paclitaxel Actavis, Paclitaxel AqVida, Paclitaxel PhaRes, Paclitaxel Sandoz, Paclitex, Paclitor, Paxane, Paxel, PXJ, Taxopac, Xelpac Premium; common vials 30 mg, 100 mg, 260 mg, 300 mg.
  • Purpose: Ovarian, endometrial, cervical recurrent/metastatic regimens.
  • Dose example: 175 mg/m² IV over 3 hours day 1 every 21 days with carboplatin/cisplatin; usually 6 cycles in adjuvant gynecologic protocols.
  • Side effects: Peripheral neuropathy, alopecia, neutropenia, hypersensitivity, myalgia, mucositis.
  • Interactions: CYP3A4/CYP2C8 inhibitors/inducers, warfarin caution, live vaccines avoid.

4. Generic name: Docetaxel

  • Therapeutic category: Anticancer chemotherapy
  • Pharmacological class: Taxane; microtubule inhibitor
  • Bangladesh available brand name: Daxotel 20/80 mg, Docefrez 20/80 mg, Docetax 20/80 mg, Docetaxel AqVida 20/80 mg, Docetaxel Axios, Docetaxel HEXAL, Docetaxel PhaRes, Docetor, Docexan, Taxedol, Taxodoc, Taxotere.
  • Purpose: Metastatic prostate cancer; some recurrent gynecologic cancers.
  • Dose example: Prostate cancer: 75 mg/m² IV every 3 weeks + prednisone; metastatic hormone-sensitive setting often 6 cycles.
  • Side effects: Neutropenia, fluid retention, neuropathy, nail changes, mucositis, alopecia.
  • Interactions: Strong CYP3A4 inhibitors/inducers, azole antifungals, macrolides, grapefruit; live vaccines avoid.

5. Generic name: Bleomycin sulfate

  • Therapeutic category: Anticancer chemotherapy
  • Pharmacological class: Antitumour antibiotic
  • Bangladesh available brand name: Bleonix 15,000 IU/vial.
  • Purpose: Testicular germ cell tumour—BEP regimen.
  • Dose example: BEP: 30,000 IU IV/IM days 1, 8, 15 every 21 days, usually 3 cycles in good-risk metastatic disease.
  • Side effects: Pulmonary fibrosis, pneumonitis, fever, skin hyperpigmentation, mucositis, anaphylactoid reaction.
  • Interactions: High oxygen exposure during anesthesia increases lung toxicity risk; prior chest radiation and G-CSF may increase pulmonary toxicity concern.

6. Generic name: Etoposide

  • Therapeutic category: Anticancer chemotherapy
  • Pharmacological class: Topoisomerase II inhibitor
  • Bangladesh available brand name: Eposide IV 100 mg/5 ml, Eposide capsule 50 mg, Eposin 100 mg/5 ml, Etopor 100 mg/5 ml, Lastet 100 mg/5 ml, Toposar capsule 50 mg.
  • Purpose: Testicular cancer BEP/EP regimen.
  • Dose example: 100 mg/m² IV days 1–5 every 21 days with cisplatin ± bleomycin.
  • Side effects: Myelosuppression, alopecia, mucositis, hypotension during infusion, secondary leukemia rare.
  • Interactions: Cyclosporine, warfarin, CYP3A4/P-gp inhibitors, live vaccines.

7. Generic name: Fluorouracil / 5-FU

  • Therapeutic category: Anticancer chemotherapy
  • Pharmacological class: Antimetabolite; pyrimidine analogue
  • Bangladesh available brand name: 5 FU PhaRes 25 mg/ml, 5-Fluril 25 mg/ml, Drucil 25 mg/ml, Fluracil, Flurotor, Fluroxan, Fluracedyl; common vial 250 mg/500 mg.
  • Purpose: Cervical/vaginal chemoradiation protocols; other SCC regimens.
  • Dose example: Protocol-dependent; often continuous infusion with radiation in selected regimens.
  • Side effects: Mucositis, diarrhea, hand-foot syndrome, myelosuppression, cardiotoxicity rare.
  • Interactions: Warfarin, phenytoin, allopurinol; DPD deficiency can cause fatal toxicity; brivudine/sorivudine contraindicated.

8. Generic name: Capecitabine

  • Therapeutic category: Oral anticancer chemotherapy
  • Pharmacological class: Oral fluoropyrimidine prodrug of 5-FU
  • Bangladesh available brand name: Cabita 500 mg, Caparen 500 mg, Capcitab 150/500 mg, Xelobine 500 mg, Syntabine 500 mg, Tysinor 150/500 mg.
  • Purpose: Radiosensitizer alternative in selected cervical protocols; other solid tumours.
  • Dose example: 825 mg/m² orally twice daily on radiotherapy days; or 1250 mg/m² twice daily days 1–14 every 21 days depending on protocol.
  • Side effects: Hand-foot syndrome, diarrhea, mucositis, myelosuppression, hyperbilirubinemia.
  • Interactions: Warfarin major interaction, phenytoin, allopurinol; DPD deficiency risk.

9. Generic name: Gemcitabine

  • Therapeutic category: Anticancer chemotherapy
  • Pharmacological class: Nucleoside antimetabolite
  • Bangladesh available brand name: Cytogem 200 mg/1 g, Gembine 200 mg/1 g, Gemcetin 200 mg/1 g, Gemcit 200 mg/1 g, Gemcitabine AqVida, Gemcitabin Hexal.
  • Purpose: Recurrent/metastatic cervical or ovarian cancer in selected regimens.
  • Dose example: 1000 mg/m² IV days 1 and 8 every 21 days; protocol dependent.
  • Side effects: Myelosuppression, flu-like symptoms, transaminitis, rash, pulmonary toxicity rare.
  • Interactions: Radiation increases toxicity/radiation recall; warfarin INR monitoring.

10. Generic name: Doxorubicin hydrochloride

  • Therapeutic category: Anticancer chemotherapy
  • Pharmacological class: Anthracycline; topoisomerase II inhibitor
  • Bangladesh available brand name: Adribin 2 mg/ml, Arodoxin, Dobixin, Doxorub, Doxorubicin PhaRes, Doxorubicin SDZ, Doxotor, Sindroxocin, Xorubin, Xorubin Aqua; common vials 10 mg/50 mg.
  • Purpose: Selected recurrent gynecologic cancers; liposomal form is more common in recurrent ovarian cancer.
  • Dose example: Conventional doxorubicin protocol-dependent; liposomal doxorubicin often 40–50 mg/m² every 28 days in recurrent ovarian protocols.
  • Side effects: Cardiotoxicity, myelosuppression, mucositis, alopecia, vesicant extravasation injury.
  • Interactions: Trastuzumab/other cardiotoxic drugs, CYP/P-gp inhibitors, live vaccines.

11. Generic name: Bevacizumab

  • Therapeutic category: Targeted anticancer therapy
  • Pharmacological class: Anti-VEGF monoclonal antibody
  • Bangladesh available brand name: Abevmy 100/400 mg, Avastin 100/400 mg, Bevacimab 100/400 mg, Bevaris 100/400 mg, Bevastim 100/400 mg, Bevixa 100/400 mg, Vegzelma 100 mg.
  • Purpose: Recurrent/metastatic cervical cancer with chemotherapy; ovarian cancer maintenance/combination in selected patients.
  • Dose example: 15 mg/kg IV every 3 weeks with chemotherapy, then maintenance until progression/toxicity depending on protocol.
  • Side effects: Hypertension, proteinuria, bleeding, thrombosis, GI perforation, poor wound healing.
  • Interactions: Surgery/wound healing risk—hold before/after major surgery; anticoagulants/NSAIDs increase bleeding concern.

12. Generic name: Pembrolizumab

  • Therapeutic category: Immunotherapy
  • Pharmacological class: PD-1 immune checkpoint inhibitor
  • Bangladesh available brand name: Brolizum 100 mg/4 ml, Pemomab 100 mg/4 ml, Pemro 100 mg/4 ml.
  • Purpose: PD-L1 positive recurrent/metastatic cervical cancer; advanced/recurrent endometrial cancer with chemotherapy or with lenvatinib depending on MMR/MSI status.
  • Dose example: 200 mg IV every 3 weeks or 400 mg IV every 6 weeks; often up to 24 months or until progression/toxicity.
  • Side effects: Immune-mediated pneumonitis, colitis, hepatitis, nephritis, endocrinopathies, rash.
  • Interactions: High-dose systemic steroids/immunosuppressants may reduce efficacy; live vaccines avoid.

13. Generic name: Olaparib

  • Therapeutic category: Targeted anticancer therapy
  • Pharmacological class: PARP inhibitor
  • Bangladesh available brand name: Inpoza 150 mg, Juparib 150 mg, Lynparib 150 mg, Olacent 100/150 mg, Olapar 100/150 mg, Olakin 150 mg, Olarigen 50/150 mg, Olatab 100 mg.
  • Purpose: BRCA-mutated/HRD-positive ovarian cancer maintenance after platinum response.
  • Dose example: 300 mg orally twice daily; maintenance commonly up to 2 years in first-line setting or until progression/toxicity depending on indication.
  • Side effects: Anemia, nausea, fatigue, thrombocytopenia, neutropenia, rare MDS/AML.
  • Interactions: Strong CYP3A inhibitors/inducers; grapefruit avoid.

14. Generic name: Lenvatinib

  • Therapeutic category: Targeted anticancer therapy
  • Pharmacological class: Multikinase inhibitor; VEGFR/FGFR inhibitor
  • Bangladesh available brand name: Enatinib 4/10 mg, Lanib 4 mg, Lenva 4/10 mg, Lenvacent 4/10 mg, Lenvakin 4/10 mg, Lenvaxen 4/10 mg, Lenvika 4/10 mg, Levagen 4/10 mg.
  • Purpose: Recurrent/metastatic endometrial cancer with pembrolizumab, especially pMMR disease in many protocols.
  • Dose example: 20 mg orally once daily + pembrolizumab 200 mg IV every 3 weeks until progression/toxicity.
  • Side effects: Hypertension, diarrhea, fatigue, hypothyroidism, proteinuria, hand-foot syndrome, QT prolongation.
  • Interactions: QT-prolonging drugs, antihypertensives adjustment, anticoagulants caution, CYP/P-gp interactions.

15. Generic name: Imiquimod

  • Therapeutic category: Topical immune response modifier
  • Pharmacological class: TLR-7 agonist
  • Bangladesh available brand name: Imiclara 5% cream, Iminod 5% cream.
  • Purpose: External genital warts; selected vulvar HSIL/preinvasive lesions—not invasive cancer treatment.
  • Dose example: Vulvar HSIL specialist protocol: 3 times weekly at night for 12–16 weeks; wash after 6–10 hours.
  • Side effects: Local redness, erosion, burning, ulceration, flu-like symptoms.
  • Interactions: Other irritant topical agents increase local reaction.

16. Generic name: Bicalutamide

  • Therapeutic category: Hormonal anticancer therapy
  • Pharmacological class: Non-steroidal androgen receptor blocker
  • Bangladesh available brand name: Bical 50 mg, Bicalon 50 mg, Calumide 50 mg, Calupros 50 mg, Casodex 50 mg.
  • Purpose: Prostate cancer with LHRH agonist/ADT; flare protection.
  • Dose example: 50 mg orally once daily with LHRH analogue.
  • Side effects: Gynecomastia, hot flush, liver enzyme elevation, fatigue, decreased libido.
  • Interactions: Warfarin effect may increase; CYP3A4 substrate caution.

17. Generic name: Goserelin

  • Therapeutic category: Hormonal anticancer therapy
  • Pharmacological class: GnRH/LHRH agonist
  • Bangladesh available brand name: Golexin 3.6/10.8 mg SC, Zoladex 3.6/10.8 mg SC.
  • Purpose: Prostate cancer androgen deprivation therapy.
  • Dose example: 3.6 mg SC every 28 days or 10.8 mg every 12 weeks; long-term unless clinically stopped.
  • Side effects: Hot flush, sexual dysfunction, osteoporosis, metabolic syndrome, QT prolongation.
  • Interactions: QT-prolonging drugs; diabetes drugs may need adjustment due to metabolic effect.

18. Generic name: Leuprorelin / Leuprolide acetate

  • Therapeutic category: Hormonal anticancer therapy
  • Pharmacological class: GnRH/LHRH agonist
  • Bangladesh available brand name: Lucrin Depot 3.75 mg, Lucrin Depot 11.25 mg.
  • Purpose: Advanced prostate cancer ADT.
  • Dose example: 3.75 mg IM/SC monthly or 11.25 mg every 3 months.
  • Side effects: Tumour flare initially, hot flush, osteoporosis, fatigue, sexual dysfunction.
  • Interactions: QT-prolonging drugs; antiandrogen often used initially to prevent flare.

19. Generic name: Abiraterone acetate

  • Therapeutic category: Hormonal targeted therapy
  • Pharmacological class: CYP17 inhibitor; androgen biosynthesis inhibitor
  • Bangladesh available brand name: Abiraxen 250 mg, Abiret 250 mg, Abiron 250 mg, Zyterone 250 mg, Zytiga 250 mg, Zytix 250/500 mg.
  • Purpose: Metastatic hormone-sensitive or castration-resistant prostate cancer with ADT.
  • Dose example: 1000 mg orally once daily empty stomach + prednisone/prednisolone 5 mg once or twice daily depending on indication.
  • Side effects: Hypertension, hypokalemia, edema, hepatotoxicity, fatigue.
  • Interactions: CYP2D6/CYP2C8 interactions; avoid strong CYP3A4 inducers; monitor with digoxin, anticoagulants, antihypertensives.

8. Prevention — কীভাবে প্রতিরোধ করবেন

  1. HPV vaccination
    • WHO recommends HPV vaccine especially girls aged 9–14 years before sexual debut; vaccination prevents HPV infection and HPV-related cancers.
  2. Cervical screening
    • HPV DNA test / Pap smear / VIA depending on national program.
    • WHO cervical cancer elimination strategy emphasizes vaccination, screening, and treatment of precancerous lesions.
  3. Safe sexual practice
    • Condom reduces HPV transmission risk but does not eliminate it completely.
    • Avoid multiple high-risk partners.
  4. Smoking cessation
    • Cervical/vulvar/vaginal/penile cancer risk কমায়।
  5. Treat precancerous lesions early
    • CIN, VIN, VAIN, penile intraepithelial neoplasia early treatment করলে invasive cancer প্রতিরোধ সম্ভব।
  6. Genital hygiene & phimosis management
    • Penile cancer preventionে hygiene, phimosis evaluation important.
  7. Genetic counselling
    • Strong family history of breast/ovarian/endometrial/colon cancer থাকলে BRCA/Lynch counselling.
  8. Early red flag referral
    • Postmenopausal bleeding
    • Postcoital bleeding
    • Non-healing genital ulcer
    • Painless testicular lump
    • Persistent bloating + early satiety
    • PSA/DRE abnormality

9. Overview / Summary

Genital cancers are malignancies of female and male reproductive/genital organs. HPV is the key preventable cause for cervical, vulvar, vaginal and penile cancers. Diagnosis depends on careful genital examination, biopsy confirmation, imaging-based staging and tumour-marker/molecular testing. Management includes surgery, radiotherapy, chemotherapy, targeted therapy, immunotherapy and palliative care. Early detection dramatically improves outcome.

10. Actionable Plan / Steps

  1. Any suspicious genital lesion or abnormal bleeding → biopsy/referral.
  2. Cervix: HPV/Pap screening + colposcopy if abnormal.
  3. Postmenopausal bleeding: TVS + endometrial biopsy.
  4. Ovarian symptoms: pelvic US + CA-125 + CT if suspicious.
  5. Testicular lump: urgent scrotal US + AFP/β-hCG/LDH.
  6. Penile ulcer/lump: biopsy + inguinal node assessment.
  7. Prostate suspicion: PSA + DRE + MRI/biopsy.
  8. Before chemotherapy: CBC, RFT, LFT, electrolytes, viral markers, fertility counselling, baseline audiology/PFT/echo where relevant.
  9. Prevention: HPV vaccine, cervical screening, smoking cessation, safe sex, early treatment of precancerous lesions

Reference List

Textbooks

  1. Robbins & Cotran Pathologic Basis of Disease, 10th ed. Female Genital Tract; Male Genital System; Neoplasia chapters.
  2. Harrison’s Principles of Internal Medicine, 21st ed. Oncology; Gynecologic malignancies; Genitourinary cancers.
  3. Davidson’s Principles and Practice of Medicine, 24th ed. Malignant disease; Women’s health; Genitourinary disease.

Guidelines / Authoritative sources

  1. CDC. Symptoms of Gynecologic Cancers, 2024.
  2. NCI. Cervical Cancer Symptoms.
  3. NCI. Testicular Cancer Treatment PDQ—signs and symptoms.
  4. CDC. Symptoms of Prostate Cancer, 2025.
  5. American Cancer Society. Signs and Symptoms of Penile Cancer, 2025.

Peer-reviewed journals with DOI

  1. Clarke MA, et al. Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis. JAMA Internal Medicine. 2018;178(9):1210–1222. DOI: 10.1001/jamainternmed.2018.2820.
  2. Goff BA, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007;109(2):221–227. DOI: 10.1002/cncr.22371.
  3. Dilley J, et al. Ovarian cancer symptoms, routes to diagnosis and survival. Gynecologic Oncology. 2020;158(2):316–322. DOI: 10.1016/j.ygyno.2020.05.002

Md.Rafiqul Islam Lipu,Date:-01-06-2026 Monday, Time:-06-48-37 Pm

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top